Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: RXGOLF who wrote (630)	4/21/1998 9:32:00 PM
From: RXGOLF	Respond to of 834

Please disregard my previous post. I have found my answers with just a little looking! Sorry(;- )!! I was at the business and just got a few too many irons in the fire!! I will continue to read. Sorry to clutter your thread and will be back more informed, RXGOLF

To: RXGOLF who wrote (630)	4/21/1998 10:49:00 PM
From: Sleepman	Read Replies (1) \| Respond to of 834

Dr. Golf: I like this company and actually got in just prior to the fanfare from the NBR mention. I think that this is interesting because they will, if approved, have the only thrombin inhibitor on the market. From talking with other MDs, I think that this class of anticoagulants will be leaders in the field--without some of the problems of heparin, and with a risk profile similar to low molecular weight heparin. Also, the heart failure product is intreguing. Good luck. Dan